首页> 外文期刊>Journal of Biosciences >The economics of biotechnology
【24h】

The economics of biotechnology

机译:生物技术经济学

获取原文
获取原文并翻译 | 示例
       

摘要

Biotechnology may change the world. Given the chances and risks of this new technology, the key question from an economic point of view is whether incentives and regulation are appropriate. Both allocational and distributional effects turn out to be important. Since James Watson and Francis Crick published their seminal paper on the structure of the DNA in Nature in 1953, research in genetics and its applications (biotechnology) has developed into an industry. Although genetics has triggered a revolution in our understanding in biology, implementation of biotechnology on an industrial scale is still rare. One might compare the current situation in biotechnology to the state of chemistry in the 1870s (Carr 2003). At that stage chemistry had just acquired a coherent theoretical framework, the periodic table. This theoretical framework was necessary to enable technology to change the production of well known products or even create a whole variety of new products (e.g. plastics) that were to become a part of our daily life. Whether biotechnology will also develop into a mass industry which will eventually change our everyday life, is a question that still has to be answered. There is a huge potential. For convenience one uses colours to distinguish the applications of biotechnology: medical (red), agricultural (green) and industrial (white) applications. Medical applications include both the production of Pharmaceuticals and genetic engineering. Some of the better known examples of medical applications are DNA sequences which are incorporated into bacteria or other other cells which are then used to produce proteins. Agricultural applications include transgenic plants whose genome has been modified by additional genes which allow them to be more resistant to weather conditions and insects, result in better yields; and still allow for less insecticides to be used. Some researchers attribute the largest potential to industrial applications with plastics and fuel as the two most promising examples. Given the huge potential of biotechnology, the question arises whether the regulatory framework in place is appropriate to encourage research and applications in biotechnology. First, I describe the current regulatory regime. Second, I analyse its implications from an economic point of view. Green biotechnology is of particular importance for the developing world. I discuss economic aspects of its implementation. This essay concludes with a summary.
机译:生物技术可能会改变世界。考虑到这种新技术的机会和风险,从经济学的角度来看,关键问题是激励措施和监管措施是否适当。分配效应和分配效应都显得很重要。自从詹姆斯·沃森(James Watson)和弗朗西斯·克里克(Francis Crick)于1953年发表有关《自然》中DNA结构的开创性论文以来,遗传学及其应用(生物技术)的研究已发展成为一个产业。尽管遗传学引发了我们对生物学的理解的革命,但是在工业规模上实施生物技术仍然很少。可以将生物技术的当前状况与1870年代的化学状态进行比较(Carr 2003)。在那个阶段,化学刚刚获得了一个连贯的理论框架,元素周期表。这个理论框架对于使技术能够改变众所周知的产品的生产,甚至创造出各种各样的新产品(例如塑料)成为我们日常生活的一部分是必要的。生物技术是否还将发展成为一个大众产业,这最终将改变我们的日常生活,这仍然是一个必须回答的问题。潜力巨大。为了方便起见,使用颜色区分生物技术的应用:医疗(红色),农业(绿色)和工业(白色)应用。医学应用包括药物生产和基因工程。医学应用的一些更广为人知的例子是DNA序列,该序列被掺入细菌或其他细胞中,然后用于生产蛋白质。农业应用包括转基因植物,其基因组已被其他基因修饰,从而使它们对天气条件和昆虫更具抵抗力,从而提高了产量;并且仍然允许使用更少的杀虫剂。一些研究人员将塑料和燃料作为两个最有前途的例子归因于工业应用的最大潜力。鉴于生物技术的巨大潜力,出现了一个问题,即现有的监管框架是否适合鼓励生物技术的研究和应用。首先,我描述当前的监管制度。其次,我从经济学的角度分析其含义。绿色生物技术对发展中国家特别重要。我讨论了其实施的经济方面。本文以总结结束。

著录项

  • 来源
    《Journal of Biosciences》 |2005年第2期|p.151-154|共4页
  • 作者

    Mathias Kuelpmann;

  • 作者单位

    HypoVereinsbank, Arabellastrasse 12, D-81925 Munich, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物科学;
  • 关键词

  • 入库时间 2022-08-17 23:37:34

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号